Gomer’s primary research focuses on tissue size regulation, tissue cell composition and fibrosing (scarring) diseases. He helped identify a human blood protein that regulates a key step in the formation of scar tissue as well as scar-like legions in fibrosing diseases such as congestive heart failure and pulmonary fibrosis. He can speak to such work, applications and commonalities, including lung inflammation and related damage caused by COVID-19 as well as potential therapeutics to treat COVID-19.
Areas of Expertise
Texas A&M in the News
Sigma Xi Research Society Honors Scientist, Communicator And Teachers With 2017 Awards
School Of Pharmacy Awarded Approximately $3 Million To Advance 3D-Printed Pediatric Medications
Pour Yourself A Second Cup: Research Shows Coffee Provides Health Benefits